ReviewFrontiers in oncology2026

Artificial intelligence in transarterial chemoembolization for hepatocellular carcinoma: from treatment response prediction to refractoriness assessment.

Xiao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.